(King's College London) One of the most ambitious large-scale projects in Human Genetics has been launched today: Epitwin will capture the subtle epigenetic signatures that mark the differences between 5,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments. The project is a collaboration between TwinsUK, a leading twin research group based at King's College London, and BGI, one of the world's largest genomic organizations headquartered in Shenzhen, China.
Read »- Anonymous
Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Biology
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infec
- Saks Fifth Avenue raises $17,000 for TGen biomedical research
- Optimizing a qPCR Gene Expression Quantification Assay for S. epidermidis Biofilms: A Comparison between Commercial Kits and a C
- A Replication Study of GWAS-Derived Lipid Genes in Asian Indians: The Chromosomal Region 11q23.3 Harbors Loci Contributing to Tr